Should Immunosuppressive Therapy Be Used in Slowly Progressive IgA Nephropathy?

被引：3
|
作者：
Feehally, John [1 ]
Barratt, Jonathan [1 ]
机构：
[1] Univ Leicester, Univ Hosp Leicester, Leicester, Leics, England
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2016年 / 68卷 / 02期
关键词：
MYCOPHENOLATE-MOFETIL; LONG-TERM; PROSPECTIVE TRIAL; CLINICAL-TRIAL; PREDNISOLONE;
D O I：
10.1053/j.ajkd.2016.03.001
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：184 / 186
页数：3
相关论文
共 50 条
  • [41] Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?
    Rasche, F. M.
    Keller, F.
    Rasche, W. G.
    Schiekofer, S.
    Boldt, A.
    Sack, U.
    Fahnert, J.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 186 (02): : 115 - 133
  • [42] Sparsentan: the first and only non-immunosuppressive therapy for the reduction of proteinuria in IgA nephropathy
    Trachtman, Howard
    Komers, Radko
    Inrig, Jula
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (06) : 571 - 576
  • [43] DOES METHYLPREDNISOLONE PULSE THERAPY DETERIORATE THE COURSE OF RAPIDLY PROGRESSIVE IGA NEPHROPATHY
    ITAMI, N
    AKUTSU, Y
    KUSUNOKI, Y
    TOCHIMARU, H
    TAKEKOSHI, Y
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1989, 143 (04): : 441 - 442
  • [44] PLASMA EXCHANGE AS AN ADJUNCTIVE THERAPY FOR RAPIDLY PROGRESSIVE IGA NEPHROPATHY: A SYSTEMATIC REVIEW
    Nguyen, Bryan
    Acharya, Chirag
    Tangpanithandee, Supawit
    Miao, Jing
    Krisanapan, Pajaree
    Thongprayoon, Charat
    Amir, Omar
    Mao, Michael
    Cheungpasitporn, Wisit
    Acharya, Prakrati
    Nguyen, Bryan
    Acharya, Chirag
    Tangpanithandee, Supawit
    Miao, Jing
    Krisanapan, Pajaree
    Thongprayoon, Charat
    Amir, Omar
    Mao, Michael A.
    Cheungpasitporn, Wisit
    Acharya, Prakrati C.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S95 - S95
  • [45] Innovative therapy for progressive IgA nephropathy with the oral encapsulated steroid preparation Nefecon®
    Sommerer, Claudia
    [J]. NEPHROLOGIE, 2023, 18 (03): : 174 - 176
  • [46] High-dose intravenous immunoglobulin therapy for progressive IgA nephropathy.
    Lukas, R
    Keller, F
    [J]. NIEREN-UND HOCHDRUCKKRANKHEITEN, 1997, 26 (08) : 362 - 365
  • [47] IGA NEPHROPATHY - HETEROGENEOUS CLINICAL PICTURES AND STEROID-THERAPY IN PROGRESSIVE CASES
    KOBAYASHI, Y
    HIKI, Y
    FUJII, K
    KUROKAWA, A
    KAMIYANA, M
    TATENO, S
    [J]. SEMINARS IN NEPHROLOGY, 1987, 7 (04) : 382 - 385
  • [48] Salvage therapy with mycophenolate mofetil in progressive IgA nephropathy after cyclophosphamide or steroid pulse therapy
    Rasche, FM
    Czock, D
    Sailer, LK
    Keller, F
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V228 - V228
  • [49] Non-immunosuppressive therapies for childhood IgA nephropathy
    Shima, Yuko
    Nakanishi, Koichi
    Yoshikawa, Norishige
    [J]. PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3057 - 3065
  • [50] Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy
    Rauen, Thomas
    Fitzner, Christina
    Eitner, Frank
    Sommerer, Claudia
    Zeier, Martin
    Otte, Britta
    Panzer, Ulf
    Peters, Harm
    Benck, Urs
    Mertens, Peter R.
    Kuhlmann, Uwe
    Witzke, Oliver
    Gross, Oliver
    Vielhauer, Volker
    Mann, Johannes F. E.
    Hilgers, Ralf-Dieter
    Floege, Juergen
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (01): : 317 - 325
12345